Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1985-03

AUTHORS

A. H. Tang, R. J. Collins

ABSTRACT

U-50488 [trans-3,4-dichloro-N-(2-(1-pyrrolidinyl) cyclohexyl)-benzeneacetamide] is a structurally novel analgesic reported to have specific kappa opioid receptor agonist properties. Potent antinociceptive activity was demonstrated in rhesus monkeys and the effect was reversed by naloxone. The overt behavioral effects of U-50488 at supra-analgesic doses more closely resembled those of ethylketocyclazocine (EKC) than morphine. In monkeys trained to discriminate a 10-micrograms/kg dose of EKC from saline, the stimulus effects generalized completely to U-50488 and other kappa agonists (e.g., bremazocine, cyclazocine), but not to the pure mu agonists. Like the other kappa agonists, U-50488 produced diuresis in monkeys by a naloxone-sensitive mechanism. In drug-naive rats offered continuous opportunity to self-administer drugs IV, most rats self-administered morphine or EKC, but none of the rats self-administered U-50488 at a rate above that of a group offered saline. Rats with continuous IV infusion of U-50488 for 3 weeks exhibited few abstinence signs and no weight loss when challenged with an injection of naloxone or after abrupt cessation of drug infusion. These experimental results support the previous reports in mice that U-50488 is a very selective kappa opioid agonist in rats and rhesus monkeys. More... »

PAGES

309-314

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00428193

DOI

http://dx.doi.org/10.1007/bf00428193

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022633609

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3923516


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analgesics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Behavior, Animal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclazocine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Discrimination (Psychology)", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diuresis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ethylketocyclazocine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Macaca mulatta", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Morphine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Naloxone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrrolidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Inbred Strains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Self Administration", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Species Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Substance Withdrawal Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Substance-Related Disorders", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Pfizer (United States)", 
          "id": "https://www.grid.ac/institutes/grid.410513.2", 
          "name": [
            "CNS Research, The Upjohn Company, 49001, Kalamazoo, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tang", 
        "givenName": "A. H.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pfizer (United States)", 
          "id": "https://www.grid.ac/institutes/grid.410513.2", 
          "name": [
            "CNS Research, The Upjohn Company, 49001, Kalamazoo, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Collins", 
        "givenName": "R. J.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1073/pnas.77.6.3691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000728370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/298759a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004788744", 
          "https://doi.org/10.1038/298759a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0278-5846(82)80130-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013444381"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0304-3940(82)90417-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016369925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0304-3940(82)90417-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016369925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(80)90107-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017322529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(80)90107-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017322529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00426372", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027702221", 
          "https://doi.org/10.1007/bf00426372"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00426372", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027702221", 
          "https://doi.org/10.1007/bf00426372"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/b978-0-12-512302-0.50010-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032055514"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(82)90132-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035316837"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(82)90132-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035316837"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(82)90159-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035428766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(82)90159-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035428766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(82)90482-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051757802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(82)90482-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051757802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00433045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053322650", 
          "https://doi.org/10.1007/bf00433045"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00433045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053322650", 
          "https://doi.org/10.1007/bf00433045"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.138.3537.143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062478263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080371882", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081581156", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081582061", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081665731", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081676497", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082102750", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083206595", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1985-03", 
    "datePublishedReg": "1985-03-01", 
    "description": "U-50488 [trans-3,4-dichloro-N-(2-(1-pyrrolidinyl) cyclohexyl)-benzeneacetamide] is a structurally novel analgesic reported to have specific kappa opioid receptor agonist properties. Potent antinociceptive activity was demonstrated in rhesus monkeys and the effect was reversed by naloxone. The overt behavioral effects of U-50488 at supra-analgesic doses more closely resembled those of ethylketocyclazocine (EKC) than morphine. In monkeys trained to discriminate a 10-micrograms/kg dose of EKC from saline, the stimulus effects generalized completely to U-50488 and other kappa agonists (e.g., bremazocine, cyclazocine), but not to the pure mu agonists. Like the other kappa agonists, U-50488 produced diuresis in monkeys by a naloxone-sensitive mechanism. In drug-naive rats offered continuous opportunity to self-administer drugs IV, most rats self-administered morphine or EKC, but none of the rats self-administered U-50488 at a rate above that of a group offered saline. Rats with continuous IV infusion of U-50488 for 3 weeks exhibited few abstinence signs and no weight loss when challenged with an injection of naloxone or after abrupt cessation of drug infusion. These experimental results support the previous reports in mice that U-50488 is a very selective kappa opioid agonist in rats and rhesus monkeys.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00428193", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085440", 
        "issn": [
          "0033-3158", 
          "1432-2072"
        ], 
        "name": "Psychopharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "85"
      }
    ], 
    "name": "Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys", 
    "pagination": "309-314", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00428193"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6bd46e7c4b6ecb81d2392eed68a94b23597c0e7181b62dd9994d9664dda00e89"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022633609"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7608025"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3923516"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00428193", 
      "https://app.dimensions.ai/details/publication/pub.1022633609"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-15T09:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000375_0000000375/records_91466_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00428193"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00428193'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00428193'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00428193'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00428193'


 

This table displays all metadata directly associated to this object as RDF triples.

211 TRIPLES      21 PREDICATES      69 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00428193 schema:about N207eacad8d4f42ef85caf459e4245eac
2 N28254eea7f2d451ba387c82b1fa64136
3 N30e770b4dd6447729a9db57f6e33ecfb
4 N5df4f96f829544c4bcc23ab665954f26
5 N5e3cdddc301843f982970a633f003908
6 N65cfe45b92ea4e908a2c3b8cba02246a
7 N7777ad8ef600425794c9d6421f3039ec
8 N87cbc426f8f04a5d916019eb6e9923a6
9 N8e36e00c5a864809a63f872521f314f4
10 N90e05ec595804dfd8a45fcaea76247c6
11 N92c6ad6d25be4af488edad3c6f910bfa
12 Na47bd164d74e47749fcbe6772e602039
13 Nb2083d24b4744dc49ac903ba8e9f059b
14 Nb9d6c794143b43fda57e34e10d31167f
15 Nc82a80e11a0f4472bd9b6027bb9b9e17
16 Ncc1ee677c70d4611851278f0af8e18b5
17 Ncdad810eb08d4b15b01b6697351d69c7
18 Ne784c57d308b4db38a87aa36d235531d
19 Nf4e4c638feba4bf688cf549196ebff24
20 Nfb0258aeb9fb4c8c99196edc4cc3842e
21 Nff1dea8e618c4faaaf5070a30737db4d
22 anzsrc-for:11
23 anzsrc-for:1115
24 schema:author Ndad79aec62634e5887b0b54343fd2790
25 schema:citation sg:pub.10.1007/bf00426372
26 sg:pub.10.1007/bf00433045
27 sg:pub.10.1038/298759a0
28 https://app.dimensions.ai/details/publication/pub.1080371882
29 https://app.dimensions.ai/details/publication/pub.1081581156
30 https://app.dimensions.ai/details/publication/pub.1081582061
31 https://app.dimensions.ai/details/publication/pub.1081665731
32 https://app.dimensions.ai/details/publication/pub.1081676497
33 https://app.dimensions.ai/details/publication/pub.1082102750
34 https://app.dimensions.ai/details/publication/pub.1083206595
35 https://doi.org/10.1016/0024-3205(80)90107-1
36 https://doi.org/10.1016/0024-3205(82)90132-1
37 https://doi.org/10.1016/0024-3205(82)90159-x
38 https://doi.org/10.1016/0024-3205(82)90482-9
39 https://doi.org/10.1016/0304-3940(82)90417-7
40 https://doi.org/10.1016/b978-0-12-512302-0.50010-9
41 https://doi.org/10.1016/s0278-5846(82)80130-9
42 https://doi.org/10.1073/pnas.77.6.3691
43 https://doi.org/10.1126/science.138.3537.143
44 schema:datePublished 1985-03
45 schema:datePublishedReg 1985-03-01
46 schema:description U-50488 [trans-3,4-dichloro-N-(2-(1-pyrrolidinyl) cyclohexyl)-benzeneacetamide] is a structurally novel analgesic reported to have specific kappa opioid receptor agonist properties. Potent antinociceptive activity was demonstrated in rhesus monkeys and the effect was reversed by naloxone. The overt behavioral effects of U-50488 at supra-analgesic doses more closely resembled those of ethylketocyclazocine (EKC) than morphine. In monkeys trained to discriminate a 10-micrograms/kg dose of EKC from saline, the stimulus effects generalized completely to U-50488 and other kappa agonists (e.g., bremazocine, cyclazocine), but not to the pure mu agonists. Like the other kappa agonists, U-50488 produced diuresis in monkeys by a naloxone-sensitive mechanism. In drug-naive rats offered continuous opportunity to self-administer drugs IV, most rats self-administered morphine or EKC, but none of the rats self-administered U-50488 at a rate above that of a group offered saline. Rats with continuous IV infusion of U-50488 for 3 weeks exhibited few abstinence signs and no weight loss when challenged with an injection of naloxone or after abrupt cessation of drug infusion. These experimental results support the previous reports in mice that U-50488 is a very selective kappa opioid agonist in rats and rhesus monkeys.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree false
50 schema:isPartOf N528d12a2f13646cf99ee97a9b829d3d8
51 Nbc7e2a2fdf3c4b8682cd496c938e5414
52 sg:journal.1085440
53 schema:name Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys
54 schema:pagination 309-314
55 schema:productId N0057936b4e4444ebbec17b48ed192a20
56 N0f7bf638265145749ef71a2756077fb4
57 N375d03476a064318b799426edcf450e5
58 N3b7228cf91094e188f82aa61916ead3c
59 Nad7d33e3ead04f9ba8a021b124f2700a
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022633609
61 https://doi.org/10.1007/bf00428193
62 schema:sdDatePublished 2019-04-15T09:04
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher N8a0177542e1d4100818e6a1baabafda1
65 schema:url http://link.springer.com/10.1007/BF00428193
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N0057936b4e4444ebbec17b48ed192a20 schema:name pubmed_id
70 schema:value 3923516
71 rdf:type schema:PropertyValue
72 N0f7bf638265145749ef71a2756077fb4 schema:name doi
73 schema:value 10.1007/bf00428193
74 rdf:type schema:PropertyValue
75 N207eacad8d4f42ef85caf459e4245eac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Humans
77 rdf:type schema:DefinedTerm
78 N28254eea7f2d451ba387c82b1fa64136 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Macaca mulatta
80 rdf:type schema:DefinedTerm
81 N30e770b4dd6447729a9db57f6e33ecfb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Analgesics
83 rdf:type schema:DefinedTerm
84 N375d03476a064318b799426edcf450e5 schema:name readcube_id
85 schema:value 6bd46e7c4b6ecb81d2392eed68a94b23597c0e7181b62dd9994d9664dda00e89
86 rdf:type schema:PropertyValue
87 N3b7228cf91094e188f82aa61916ead3c schema:name nlm_unique_id
88 schema:value 7608025
89 rdf:type schema:PropertyValue
90 N528d12a2f13646cf99ee97a9b829d3d8 schema:volumeNumber 85
91 rdf:type schema:PublicationVolume
92 N5df4f96f829544c4bcc23ab665954f26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Animals
94 rdf:type schema:DefinedTerm
95 N5e3cdddc301843f982970a633f003908 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Time Factors
97 rdf:type schema:DefinedTerm
98 N65cfe45b92ea4e908a2c3b8cba02246a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Rats, Inbred Strains
100 rdf:type schema:DefinedTerm
101 N6edbc8f811f74ff087fde5e1f27eae81 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
102 schema:familyName Tang
103 schema:givenName A. H.
104 rdf:type schema:Person
105 N74da546b83a24cfd8c815f9f784c917c schema:affiliation https://www.grid.ac/institutes/grid.410513.2
106 schema:familyName Collins
107 schema:givenName R. J.
108 rdf:type schema:Person
109 N7777ad8ef600425794c9d6421f3039ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Behavior, Animal
111 rdf:type schema:DefinedTerm
112 N79fdcc838cc34e05b5025777ba29e15d rdf:first N74da546b83a24cfd8c815f9f784c917c
113 rdf:rest rdf:nil
114 N87cbc426f8f04a5d916019eb6e9923a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Self Administration
116 rdf:type schema:DefinedTerm
117 N8a0177542e1d4100818e6a1baabafda1 schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 N8e36e00c5a864809a63f872521f314f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Species Specificity
121 rdf:type schema:DefinedTerm
122 N90e05ec595804dfd8a45fcaea76247c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Ethylketocyclazocine
124 rdf:type schema:DefinedTerm
125 N92c6ad6d25be4af488edad3c6f910bfa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Cyclazocine
127 rdf:type schema:DefinedTerm
128 Na47bd164d74e47749fcbe6772e602039 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Discrimination (Psychology)
130 rdf:type schema:DefinedTerm
131 Nad7d33e3ead04f9ba8a021b124f2700a schema:name dimensions_id
132 schema:value pub.1022633609
133 rdf:type schema:PropertyValue
134 Nb2083d24b4744dc49ac903ba8e9f059b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Male
136 rdf:type schema:DefinedTerm
137 Nb9d6c794143b43fda57e34e10d31167f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Morphine
139 rdf:type schema:DefinedTerm
140 Nbc7e2a2fdf3c4b8682cd496c938e5414 schema:issueNumber 3
141 rdf:type schema:PublicationIssue
142 Nc82a80e11a0f4472bd9b6027bb9b9e17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
144 rdf:type schema:DefinedTerm
145 Ncc1ee677c70d4611851278f0af8e18b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Pyrrolidines
147 rdf:type schema:DefinedTerm
148 Ncdad810eb08d4b15b01b6697351d69c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Diuresis
150 rdf:type schema:DefinedTerm
151 Ndad79aec62634e5887b0b54343fd2790 rdf:first N6edbc8f811f74ff087fde5e1f27eae81
152 rdf:rest N79fdcc838cc34e05b5025777ba29e15d
153 Ne784c57d308b4db38a87aa36d235531d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Naloxone
155 rdf:type schema:DefinedTerm
156 Nf4e4c638feba4bf688cf549196ebff24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Substance Withdrawal Syndrome
158 rdf:type schema:DefinedTerm
159 Nfb0258aeb9fb4c8c99196edc4cc3842e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Rats
161 rdf:type schema:DefinedTerm
162 Nff1dea8e618c4faaaf5070a30737db4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Substance-Related Disorders
164 rdf:type schema:DefinedTerm
165 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
166 schema:name Medical and Health Sciences
167 rdf:type schema:DefinedTerm
168 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
169 schema:name Pharmacology and Pharmaceutical Sciences
170 rdf:type schema:DefinedTerm
171 sg:journal.1085440 schema:issn 0033-3158
172 1432-2072
173 schema:name Psychopharmacology
174 rdf:type schema:Periodical
175 sg:pub.10.1007/bf00426372 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027702221
176 https://doi.org/10.1007/bf00426372
177 rdf:type schema:CreativeWork
178 sg:pub.10.1007/bf00433045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053322650
179 https://doi.org/10.1007/bf00433045
180 rdf:type schema:CreativeWork
181 sg:pub.10.1038/298759a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004788744
182 https://doi.org/10.1038/298759a0
183 rdf:type schema:CreativeWork
184 https://app.dimensions.ai/details/publication/pub.1080371882 schema:CreativeWork
185 https://app.dimensions.ai/details/publication/pub.1081581156 schema:CreativeWork
186 https://app.dimensions.ai/details/publication/pub.1081582061 schema:CreativeWork
187 https://app.dimensions.ai/details/publication/pub.1081665731 schema:CreativeWork
188 https://app.dimensions.ai/details/publication/pub.1081676497 schema:CreativeWork
189 https://app.dimensions.ai/details/publication/pub.1082102750 schema:CreativeWork
190 https://app.dimensions.ai/details/publication/pub.1083206595 schema:CreativeWork
191 https://doi.org/10.1016/0024-3205(80)90107-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017322529
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/0024-3205(82)90132-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035316837
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1016/0024-3205(82)90159-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1035428766
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1016/0024-3205(82)90482-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051757802
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1016/0304-3940(82)90417-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016369925
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1016/b978-0-12-512302-0.50010-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032055514
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/s0278-5846(82)80130-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013444381
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1073/pnas.77.6.3691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000728370
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1126/science.138.3537.143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062478263
208 rdf:type schema:CreativeWork
209 https://www.grid.ac/institutes/grid.410513.2 schema:alternateName Pfizer (United States)
210 schema:name CNS Research, The Upjohn Company, 49001, Kalamazoo, MI, USA
211 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...